Table 2.

Univariate analysis

	Univariate analysis
	p-value	HR	95% CI for HR
Age (continuously)	0.002	1.063	1.022–1.105
Female Gender (vs. male)	0.05	0.127	0.016–0.998
Localization (cervical vs. thoracic)	0.228	0.509	0.170–1.526
Mutation H3F3A (yes vs.no)	0.03	4.164	1.038–15.801
ATRX loss (yes vs. no)	0.085	0.119	0.011–1.337
Necrosis (yes vs. no)	0.650	0.045	0.136–9.092
Endothelial Proliferation (yes vs. no)	0.222	2.108	0.637–6.977
Mitosis (continuously)	0.059	1.653	0.981–2.784
Ki-67 (continuously)	0.057	10.428	0.75–43.398
Tumor Subtype	0.002	0.42	0.244–0.724
Adjuvant Treatment (yes vs no)	0.154	3.063	0.657–14.289